AHX Share Price

Open 0.81 Change Price %
High 0.89 1 Day 0.01 1.23
Low 0.80 1 Week 0.00 0.00
Close 0.82 1 Month 0.00 0.00
Volume 24105 1 Year 0.00 0.00
52 Week High 138.86
52 Week Low 104.70
AHX Important Levels
Resistance 2 0.90
Resistance 1 0.87
Pivot 0.84
Support 1 0.77
Support 2 0.74
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
BTO 3.38 1.81%
BTO 3.38 1.81%
SC 60.83 -0.44%
PRE 0.64 0.00%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
DA-A 0.23 35.29%
ANX 0.06 20.00%
ANX 0.06 20.00%
CUM 0.90 13.92%
CUM 0.90 13.92%
CXA-B 1.10 11.11%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
PWC 0.10 -16.67%
PWC 0.10 -16.67%
TOS 2.25 -11.42%
TOS 2.25 -11.42%
BX 0.85 -10.53%
BX 0.85 -10.53%
CET 0.48 -9.43%
CET 0.48 -9.43%
DNT 0.10 -9.09%
More..

Adherex Technologies, Inc. (TSE: AHX)

AHX Technical Analysis 2
As on 4th Sep 2014 AHX Share Price closed @ 0.82 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.78 & Strong Sell for SHORT-TERM with Stoploss of 1.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
AHX Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
AHX Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.adherex.com
AHX Address
AHX
68 TW Alexander Drive
PO Box 13628
Research Triangle Park, NC 27709
United States
Phone: 919-636-4530
Fax: 919-890-0490
Interactive Technical Analysis Chart Adherex Technologies, Inc. ( AHX TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Adherex Technologies, Inc.
AHX Business Profile
Adherex Technologies Inc., together with its subsidiaries, operates as a development stage biopharmaceutical company with a portfolio of product candidates under development for use in the treatment of cancer. Its lead product candidates include Sodium Thiosulfate, a water soluble thiol compound, which is in phase III clinical trials that act as a chemical reducing agent for the prevention of cisplatin induced hearing loss or ototoxicity in children; and Eniluracil, an oral irreversible dihydropyrimidine dehydrogenase inhibitor for the rapid break down of 5-FU in the body, which has completed phase II clinical trials for the treatment of metastatic breast cancer. Adherex Technologies Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina.